BURLINGTON, Mass.-Infraredx, a Nipro Company, a pioneer in intravascular imaging for mapping coronary artery disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug ...
U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Infraredx, a Nipro Company, a pioneer in intravascular imaging for mapping coronary artery disease, announced today that it has received 510(k) clearance from the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback